Item 9A. Controls and Procedures
Item 9A.
Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
As of December 31, 2024, our Company
evaluated the effectiveness and design and operation of its disclosure controls and procedures. Our Company’s disclosure controls
and procedures are the controls and other procedures that we designed to ensure that our Company records, processes, summarizes, and reports
in a timely manner the information that it must disclose in reports that our Company files with or submits to the Securities and Exchange
Commission. Our principal executive officer and principal financial officer reviewed and participated in this evaluation. Based on this
evaluation, our Company made the determination that its disclosure controls and procedures were effective.
Management’s Annual Report on Internal Control Over Financial
Reporting
Our management is responsible
for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f)
and 15d-15(f). Under the supervision and with the participation of management, including our principal executive officer and principal
financial officer, we conducted an evaluation of the effectiveness of our internal controls over financial reporting based on the framework
in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").
Based on this evaluation, management has concluded that our internal control over financial reporting was effective as of December 31,
2024.
The Company’s internal control
over financial reporting includes policies and procedures that (1) pertain to maintenance of records that, in reasonable detail, accurately
and fairly reflect transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that
receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the
Company’s assets that could have a material effect on the financial statements.
Our management, including our
principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal control over
financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide
only reasonable, not absolute, assurance that the control system’s objectives will be met. Internal control over financial reporting
is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures.
In addition, the design of any system of controls is based in part on certain assumptions about the likelihood of future events, and controls
may become inadequate if conditions change. There can be no assurance that any design will succeed in achieving its stated goals under
all potential future conditions.
36
Attestation Report of
the Registered Public Accounting Firm
This
Annual Report does not include an attestation report of our Company’s independent registered public accounting firm regarding internal
control over financial reporting. Management’s report was not subject to attestation by our Company’s registered public accounting
firm pursuant to rules of the Securities and Exchange Commission that permit our Company to provide only management’s attestation
in this Annual Report.
Changes in Internal Control Over Financial Reporting
No change in our Company’s
internal control over financial reporting occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely
to materially affect, our internal control over financial reporting.
Item 9B.
Other Information
(a) Lincoln
Park Purchase Agreement
On March 17, 2025,
Lightwave Logic, Inc. (the “ Company ”), entered into a purchase agreement (the “ Purchase Agreement ”)
with Lincoln Park Capital Fund, LLC (“ Lincoln Park ” or “ Investor ”) (each, a “ Party ”,
and together, the “ Parties ”), which provides that, upon the terms and subject to the conditions and limitations set
forth therein, the Company may sell to Lincoln Park up to $30,000,000 of shares (the “ Purchase Shares ”) of its common
stock, par value $0.001 per share (the “ Common Stock ”).
Concurrently with entering
into the Purchase Agreement, the Company also entered into a registration rights agreement with Lincoln Park, pursuant to which it agreed
to provide Lincoln Park with certain registration rights related to the shares issued under the Purchase Agreement (the “ Registration
Rights Agreement ”).
Beginning one
business day following the date of satisfaction of certain conditions set forth in the Purchase Agreement (the “ Commencement
Date ”) and over the thirty-six (36) month term following the Commencement Date, the Company has the right, but not the
obligation, on any business day selected by the Company (each, a “ Purchase
Date ”), to require Lincoln Park to purchase up to 250,000 shares of Common Stock (the “ Regular
Purchase Share Limit ”) (each such purchase, a “ Regular
Purchase ”). Lincoln Park’s committed obligation under each Regular Purchase shall not exceed $3,000,000 (subject
to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar
transaction as provided in the Purchase Agreement), provided that the Parties may mutually agree at any time to increase the Regular
Purchase Share Limit. The Company shall have the right to submit multiple Regular Purchase notices to the Investor as often as every
business day, provided that the Company has not failed to deliver shares for the most recent prior Regular Purchase.
The purchase price
per share for each such Regular Purchase (the “ Purchase Price ”) shall be equal to the lesser of: (i) the lowest sale
price of the Common Stock during the Purchase Date and (ii) the average of the three (3) lowest closing sale prices of the Common Stock
during the ten (10) business days immediately preceding such Purchase Date.
In addition to Regular
Purchases and provided that the Company has directed a Regular Purchase in full, the Company in its sole discretion may require Lincoln
Park on each Purchase Date to purchase on the following business day (each, an “ Accelerated Purchase Date ”) up to the
lesser of: (i) three (3) times the number of shares purchased pursuant to such Regular Purchase and (ii) 30% of the trading volume on
Nasdaq during all or, if certain trading volume or market price thresholds specified in the Purchase Agreement are crossed on the applicable
Accelerated Purchase Date, the portion of the normal trading hours on the applicable Accelerated Purchase Date prior to such time that
any one of such thresholds is crossed, which period of time on the applicable Accelerated Purchase Date (each such purchase, an “ Accelerated
Purchase ”).
The purchase price
per share for each such Accelerated Purchase shall be equal to the lesser of: (i) the closing sale price on the Accelerated Purchase Date
or (ii) 96.5% of the Accelerated Purchase Date’s volume weighted average price (the “ Accelerated Purchase Price ”).
The Parties may mutually agree to increase the number of shares of Common Stock sold to the Investor pursuant to any Accelerated Purchase.
The Company may also
direct Lincoln Park, on any business day on which an Accelerated Purchase has been completed and all of the shares to be purchased thereunder
have been properly delivered to Lincoln Park in accordance with the Purchase Agreement, to make additional purchases upon the same terms
as an Accelerated Purchase, (an “ Additional Accelerated Purchase ”). The Company may direct multiple Additional Accelerated
Purchases in a day provided that delivery of shares has been completed with respect to any prior Regular and Accelerated Purchases that
Lincoln Park has purchased.
37
The purchase price
of Regular Purchases, Accelerated Purchases and Additional Accelerated Purchases and the minimum closing sale price for a Regular Purchase
will be adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction
occurring during the business days used to compute the purchase price. The aggregate number of shares that the Company can sell to Lincoln
Park under the Purchase Agreement may in no case exceed 24,910,904 shares (subject to adjustment as described above), which is equal to
approximately 19.99% of the shares of Common Stock outstanding immediately prior to the execution of the Purchase Agreement (the “ Exchange
Cap ”), unless (i) stockholder approval is obtained to issue shares above the Exchange Cap, in which the Exchange Cap will no
longer apply, or (ii) the average price of all applicable sales of Common Stock to Lincoln Park under the Purchase Agreement equals or
exceeds $1.06 per share (subject to adjustment as described above) (which represents the lower of (A) the official closing price
of the Common Stock on Nasdaq immediately preceding the signing of the Purchase Agreement and (B) the average official closing price of
the Common Stock on Nasdaq for the five consecutive trading days ending on the trading day immediately preceding the date of the Purchase
Agreement). In any event, the Purchase Agreement specifically provides that the Company may not issue or sell any shares of Common Stock
under the Purchase Agreement if such issuance or sale would breach any applicable rules or regulations of Nasdaq.
The Purchase Agreement
also prohibits the Company from directing Lincoln Park to purchase any shares of Common Stock if those shares, when aggregated with all
other shares of Common Stock then beneficially owned by Lincoln Park, would result in Lincoln Park beneficially owning more than 4.99%
of its outstanding shares of Common Stock, or at the option of Lincoln Park following the satisfaction of certain conditions, 9.99% of
the outstanding shares of Common Stock.
On March 17, 2025,
we issued 245,098 shares of Common Stock to Lincoln Park as an initial fee for its commitment to purchase shares of our common stock under
the Purchase Agreement (the “ Initial Commitment Shares ”). We may issue up to 490,196 additional shares of Common Stock
pro-rata in connection with the sale of Purchase Shares (the “ Additional Commitment Shares ” and together with the Initial
Commitment Shares, the “ Commitment Shares ”).
The Purchase Agreement
contains customary representations, warranties, covenants, Suspension Events (as defined in the Purchase Agreement), closing conditions,
indemnification and termination provisions. During any Suspension Event specified in the Purchase Agreement, we may not initiate any sales
to Lincoln Park until such Suspension Event is cured. Lincoln Park does not have the right to terminate the Purchase Agreement upon the
occurrence of a Suspension Event. There are no restrictions on future financings, rights of first refusal, participation rights, penalties
or liquidated damages in the Purchase Agreement or the Registration Rights Agreement, other than the Company’s agreement not to
enter into any Variable Rate Transactions (as defined in the Purchase Agreement) with any third party, subject to certain exceptions set
forth in the Purchase Agreement, over the thirty-six (36) month term following the date of the Purchase Agreement (irrespective of any
earlier termination of the Purchase Agreement in accordance with the terms therein).
The Purchase Agreement
may be terminated by the Company at any time after the Commencement Date, at its sole discretion, without any cost or penalty, by giving
one business day notice to Lincoln Park to terminate the Purchase Agreement. Lincoln Park has covenanted not to cause or engage in any
manner whatsoever, any direct or indirect short selling or hedging of the Common Stock.
The foregoing is a
summary description of certain terms of the Purchase Agreement and the Registration Rights Agreement and, by its nature, is incomplete.
Copies of the Purchase Agreement and the Registration Rights Agreement are filed as Exhibits 10.33 and 10.34 attached hereto. The foregoing
descriptions of the Purchase Agreement and the Registration Rights Agreement are qualified in their entirety by reference to such exhibits.
The Purchase Agreement and Registration Rights Agreement contain customary representations and warranties, covenants and indemnification
provisions that the parties made to, and solely for the benefit of, each other in the context of all of the terms and conditions of such
agreements and in the context of the specific relationship between the parties thereto. The provisions of the Purchase Agreement and
the Registration Rights Agreement, including any representations and warranties contained therein, are not for the benefit of any party
other than the parties thereto and are not intended as documents for investors and the public to obtain factual information about the
current state of affairs of the parties thereto. Rather, investors and the public should look to other disclosures contained in the Company’s
annual, quarterly and current reports it may file with the Securities and Exchange Commission.
The information contained in this Item
9B shall not constitute an offer to sell or the solicitation of an offer to buy the shares of the Company’s Common Shares discussed
herein, nor shall there be any offer, solicitation or sale of the shares in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
(b) Trading Arrangements
During
the three months ended December 31, 2024, none of
our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction or written
plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under
the Exchange Act or any “non-Rule 10b5-1 arrangement” as defined in Item 408(c) of Regulation S-K.
Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
None.
38
PART III
Item 10.
Directors, Executive Officers and Corporate Governance.
Information
required under this Item will be contained in our definitive proxy statement, which will be filed within 120 days of December 31, 2024,
our most recent fiscal year end, and is incorporated herein by reference.
Item 11.
Executive Compensation.
Information
required under this Item will be contained in our definitive proxy statement, which will be filed within 120 days of December 31, 2024,
our most recent fiscal year end, and is incorporated herein by reference.
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Information
required under this Item will be contained in our definitive proxy statement, which will be filed within 120 days of December 31, 2024,
our most recent fiscal year end, and is incorporated herein by reference.
Item 13.
Certain Relationships and Related Transactions, and Director Independence.
Information
required under this Item will be contained in our definitive proxy statement, which will be filed within 120 days of December 31, 2024,
our most recent fiscal year end, and is incorporated herein by reference.
Item 14.
Principal Accountant Fees and Services.
Information
required under this Item will be contained in our definitive proxy statement, which will be filed within 120 days of December 31, 2024,
our most recent fiscal year end, and is incorporated herein by reference.
39
PART IV
Item 15.
Exhibits and Financial Statement Schedules
(a)
The following Audited Financial Statements are filed as part of this Form 10-K Report:
Report of Independent Registered Public Accounting Firm
Balance Sheets
Statements of Comprehensive Loss
Statement of Stockholders’ Equity
Statements of Cash Flows
Notes to Financial Statements
(b)
The following exhibits are filed as part of this report.
Exhibit No.
Description of Exhibit
Location
3.1
Articles of Incorporation
Incorporated by reference to Company’s Form 10-SB as filed with the SEC on April 13, 2007
3.2
Certificate of Amendment to Articles of Incorporation
Incorporated by reference to Company’s Definitive Schedule 14C Information Statement as filed with the SEC on February 19, 2008
3.3
Certificate of Amendment to Articles of Incorporation
Incorporated by reference to Company’s Form S-1 Registration Statement as filed with the SEC on August 3, 2015
3.4
Second Amended and Restated Bylaws – June 18, 2024
Incorporated by reference to the Company’s Form 10-Q as filed with the SEC on June 25, 2024
4.1
Description of Registrant’s Securities
Filed herewith
10.1
Employee Agreement - Yves Lemaitre
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on December 13, 2024.
10.2
Employee Agreement - Thomas Zelibor
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on December 13, 2024
10.3
Employee Agreement - James Marcelli
Incorporated by reference to Company’s Form 10-Q as filed with the SEC on August 12, 2015
10.4
Employee Agreement Amendment - James Marcelli
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 20, 2021
10.5
Employee Agreement Amendment - James Marcelli
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on January 21, 2022
10.6
Employee Agreement Amendment – James Marcelli
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 27, 2023
10.7
Employee Agreement Amendment – James S. Marcelli
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on June 25, 2024
10.8
Employee Agreement – Michael Lebby
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on March 22, 2017
10.9
Employee Agreement Amendment - Michael Lebby
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 20, 2021
10.10
Employee Agreement Amendment - Michael Lebby
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on January 21, 2022
10.11
Employee Agreement Amendment – Michael Lebby
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 27, 2023
10.12
Employee Agreement Amendment – Michael Lebby
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on June 25, 2024
10.13
Form of Executive Paid Time Off Waiver Agreement
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on March 16, 2018
10.14
Form of Director Agreement
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on March 16, 2018
10.15
Form of Director and Officer Indemnification Agreement
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on January 21, 2022
10.16
Form of Director’s Non-Disclosure Agreement
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on March 16, 2018
40
Exhibit No.
Description of Exhibit
Location
10.17
Operations Committee Charter
Incorporated by reference to the Company’s Form 10-Q as filed with the SEC on August 15, 2016
10.18
Statement of Operations Committee Work - Frederick J. Leonberger
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 3, 2017
10.19
Statement of Operations Committee Work - Siraj Nour El-Ahmadi
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on March 31, 2021
10.20
2007 Employee Stock Plan
Incorporated by reference to Company’s Definitive Schedule 14C Information Statement as filed with the SEC on February 19, 2008
10.21
2007 Employee Stock Plan Amendment
Incorporated by reference to Company’s Definitive Schedule 14A Proxy Statement as filed with the SEC on July 22, 2014
10.22
2016 Equity Incentive Plan
Incorporated by reference to Appendix A to the Company’s Definitive Schedule 14A filed with the SEC on April 20, 2016
10.23
2016 Equity Incentive Plan Amendment
Incorporated by reference to Appendix A to the Company’s Definitive Schedule 14A filed with the SEC on April 12, 2019
10.24
2016
Equity Incentive Plan Amendment No. 2
Incorporated by reference to Appendix A to the Company’s Definitive Schedule 14A filed with the SEC on April 14, 2023
10.25
Form of Non-qualified Stock Option Award Agreement - Employees
Incorporated by reference to the Company’s Annual Report on Form 10-K as filed with the SEC on March 17, 2017
10.26
Form of Non-qualified Stock Option Award Agreement - Executive Officers
Incorporated by reference to the Company’s Annual Report on Form 10-K as filed with the SEC on March 17, 2017
10.27
Form of Non-qualified Stock Option Award Agreement - Non Employee Directors
Incorporated by reference to the Company’s Annual Report on Form 10-K as filed with the SEC on March 17, 2017
10.28
Form of Restricted Stock Award Agreement -Non Employee Directors
Incorporated by reference to the Company’s Annual Report on Form 10-K as filed with the SEC on March 1, 2022
10.29
Lease Agreement dated October 26, 2017
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on November 2, 2017
10.30
First Amendment to the October 26, 2017 Lease Agreement dated November 22, 2022
Incorporated by reference to Company’s Form 10-K as filed with the SEC on March 1, 2023
10.31
Purchase Agreement, dated February 28, 2023, by and between the Company and Lincoln Park
Incorporated by reference to Company’s Form 10-K as filed with the SEC on March 1, 2023
10.32
Registration Rights Agreement, dated February 28, 2023, by and between the Company and Lincoln Park
Incorporated by reference to Company’s Form 10-K as filed with the SEC on March 1, 2023
10.33
Purchase Agreement, dated March 17, 2025, by and between the Company and Lincoln Park
Filed herewith
10.34
Registration Rights Agreement, dated March 17, 2025, by and between the Company and Lincoln Park
Filed herewith
14.1
Code of Ethics and Business Conduct
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on March 16, 2018
16.1
Letter from Morison Cogen LLP to the Securities and Exchange Commission dated October 4, 2024
Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on October 4, 2024
19.1
Insider Trading Policy
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on February 29, 2024
21.1
Subsidiaries of the Registrant
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on February 29, 2024
41
Exhibit No.
Description of Exhibit
Location
23.1
Consent of Independent Registered Public Accounting Firm - Stephano Slack LLC
Filed herewith
23.2
Consent of Independent Registered Public Accounting Firm - Morison Cogen LLP
Filed herewith
31.1
Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Executive Officer of the Company.
Filed herewith
31.2
Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Financial Officer of the Company.
Filed herewith
32.1
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Executive Officer of the Company.
Furnished
32.2
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Financial Officer of the Company.
Furnished
97.1
Compensation Clawback Policy
Incorporated by reference to the Company’s Form 10-K as filed with the SEC on February 29, 2024
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
Item 16.
Form 10-K Summary
None
42
SIGNATURES
Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
LIGHTWAVE LOGIC, INC.
Registrant
By:
/s/ Yves LeMaitre
Yves LeMaitre,
Chief Executive Officer
(Principal Executive Officer)
Date: March 18, 2025
Pursuant to the requirements of
the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.
Signature
Title
Date
/s/ Yves LeMaitre
Chief Executive Officer, Principal Executive Officer, Director
March 18, 2025
Yves LeMaitre
/s/ James S. Marcelli
Chief Financial Officer, Chief Operating Officer, Principal Financial/Accounting Officer, Secretary, Director
March 18, 2025
James S. Marcelli
/s/ Ronald A. Bucchi
Director, Chair of the Board of Directors
March 18, 2025
Ronald A. Bucchi
/s/ Siraj Nour El-Ahmadi
Director
March 18, 2025
Siraj Nour El-Ahmadi
/s/ Craig Ciesla
Director
March 18, 2025
Craig Ciesla
/s/ Laila Partridge
Director
March 18, 2025
Laila Partridge
/s/ Thomas M. Connelly, Jr.
Director
March 18, 2025
Thomas M. Connelly, Jr.
43
LIGHTWAVE LOGIC, INC.
FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
CONTENTS
PAGE
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID Number 3523 )
F-2 - F-3
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID Number 00 536 )
F-4 - F-5
BALANCE SHEETS
F-6
STATEMENTS OF COMPREHENSIVE LOSS
F-7
STATEMENTS OF STOCKHOLDERS' EQUITY
F-8
STATEMENTS OF CASH FLOWS
F-9
NOTES TO FINANCIAL STATEMENTS
F-10 - F-29
F- 1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Board of Directors and
Stockholders of Lightwave Logic, Inc.
Opinions on the Financial Statements and Internal
Control over Financial Reporting
We have audited the accompanying balance sheet of
Lightwave Logic, Inc. (the Company) as of December 31, 2024, and the related statements of comprehensive loss, stockholders’ equity,
and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the financial statements).
In our opinion, the financial statements present fairly,
in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash
flows for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal
control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal
control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to
assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
F- 2
To the Board of Directors and
Stockholders of Lightwave Logic, Inc.
(Continued)
Critical Audit Matters
Critical audit matters are matters arising from
the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and
that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging,
subjective, or complex judgments. We determined that there are no critical audit matters.
/s/ Stephano Slack LLC
We have served as the Company’s auditor since
2024.
Wayne, Pennsylvania
March 18, 2025
F- 3
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Board of Directors and
Stockholders of Lightwave Logic, Inc.
Opinions on the Financial Statements and Internal
Control over Financial Reporting
We have audited the accompanying balance sheet of
Lightwave Logic, Inc. (the Company) as of December 31, 2023, and the related statements of comprehensive loss, stockholders’ equity,
and cash flows for the year then ended, and the related notes (collectively referred to as the financial statements). We also have audited
the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control
– Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the financial statements referred
to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its
operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States
of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting
as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.
Basis for Opinions
The Company’s management is responsible for
these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness
of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial
Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s
internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was
maintained in all material respects.
Our audit of the financial statements included
performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures
in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing
and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing
such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.
F- 4
To the Board of Directors and
Stockholders of Lightwave Logic, Inc.
(Continued)
Definition
and Limitations of Internal Control over Financial Reporting
A
company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance
with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection
of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.
Critical
Audit Matters
Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.
/s/
Morison Cogen LLP
We
served as the Company’s auditor from 2005 to 2024.
Blue
Bell, Pennsylvania
February
29, 2024
F- 5
LIGHTWAVE LOGIC, INC.
BALANCE SHEETS
December 31, 2024
December 31, 2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$ 27,667,964
$ 31,432,087
Accounts Receivable
45,565
30,376
Prepaid expenses and other current assets
401,741
1,237,621
TOTAL CURRENT ASSETS
28,115,270
32,700,084
PROPERTY AND EQUIPMENT - net of accumulated depreciation of $ 6,037,723 and $ 4,674,560
5,691,545
4,990,790
OTHER ASSETS
Intangible assets - net of accumulated amortization of $ 771,631 and $ 659,250
1,355,445
1,254,501
Operating Lease - Right of Use - Building
2,645,723
2,838,210
TOTAL OTHER ASSETS
4,001,168
4,092,711
TOTAL ASSETS
$ 37,807,983
$ 41,783,585
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable
$ 515,955
$ 1,447,596
Accrued bonuses and accrued expenses
877,165
599,430
Accounts payable and accrued expenses - related parties
200,779
313,483
Contract liability
23,208
39,875
Deferred lease liability
—
38,297
Operating lease liability
168,289
144,120
TOTAL CURRENT LIABILITIES
1,785,396
2,582,801
LONG TERM LIABILITIES
Operating lease liability
2,598,682
2,766,970
TOTAL LONG TERM LIABILITIES
2,598,682
2,766,970
TOTAL LIABILITIES
4,384,078
5,349,771
STOCKHOLDERS' EQUITY
Preferred
stock, $ 0.001 par value, 1,000,000 authorized, no shares issued or outstanding
—
—
Common stock $ 0.001 par value, 250,000,000 authorized,
123,301,653 and 118,137,309 issued and outstanding at
December 31, 2024 and December 31, 2023
123,302
118,137
Additional paid-in-capital
184,363,772
164,619,363
Deferred compensation
( 656,735 )
( 432,293 )
Accumulated deficit
( 150,406,434 )
( 127,871,393 )
TOTAL STOCKHOLDERS' EQUITY
33,423,905
36,433,814
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$ 37,807,983
$ 41,783,585
The accompanying notes are an integral part of these
financial statements.
F- 6
LIGHTWAVE LOGIC, INC.
STATEMENTS OF COMPREHENSIVE LOSS
FOR THE YEARS ENDED DECEMBER
31, 2024 AND 2023
2024
2023
NET SALES
$ 95,605
$ 40,502
COST AND EXPENSE
Cost of sales
7,395
2,513
Research and development
16,806,548
15,903,689
General and administrative
6,370,805
5,359,565
TOTAL COST AND EXPENSE
23,184,748
21,265,767
LOSS FROM OPERATIONS
( 23,089,143 )
( 21,225,265 )
OTHER INCOME (EXPENSE)
Interest income
926,854
657,546
Commitment fee
( 154,210 )
( 673,578 )
(Loss) gain on disposal of property and equipment and intangible assets
( 213,440 )
215,509
Other (expense)
( 5,102 )
( 12,244 )
NET LOSS
$ ( 22,535,041 )
$ ( 21,038,032 )
LOSS PER SHARE
Basic
$ ( 0.19 )
$ ( 0.18 )
Diluted
$ ( 0.19 )
$ ( 0.18 )
WEIGHTED AVERAGE NUMBER OF SHARES
Basic
120,599,885
115,467,300
Diluted
120,599,885
115,467,300
The accompanying notes are an integral part of these financial statements.
F- 7
LIGHTWAVE LOGIC, INC.
STATEMENTS OF STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023
Additional
Number of
Common
Paid-in
Deferred
Accumulated
Shares
Stock
Capital
Compensation
Deficit
Total
BALANCE AT DECEMBER 31, 2023
118,137,309
$ 118,137
$ 164,619,363
$ ( 432,293 )
$ ( 127,871,393 )
$ 36,433,814
Common stock issued to institutional investor
3,850,000
3,850
12,363,115
—
—
12,366,965
Common stock issued for commitment shares
41,956
42
154,168
—
—
154,210
Common stock sales at the market by investment banking company
551,501
552
1,779,424
—
—
1,779,976
Exercise of options
375,000
375
245,725
—
—
246,100
Exercise of warrants
119,000
119
91,131
—
—
91,250
Options issued for services
—
—
4,440,003
—
—
4,440,003
Restricted stock awards issued for future services
226,887
227
670,843
( 671,070 )
—
—
Deferred compensation
—
—
—
446,628
—
446,628
Net loss for the year ended December 31, 2024
—
—
—
—
( 22,535,041 )
( 22,535,041 )
BALANCE AT DECEMBER 31, 2024
123,301,653
$ 123,302
$ 184,363,772
$ ( 656,735 )
$ ( 150,406,434 )
$ 33,423,905
Additional
Number of
Common
Paid-in
Deferred
Accumulated
Shares
Stock
Capital
Compensation
Deficit
Total
BALANCE AT DECEMBER 31, 2022
112,882,793
$ 112,883
$ 134,406,825
$ ( 133,324 )
$ ( 106,833,361 )
$ 27,553,023
Common stock issued to institutional investor
3,650,400
3,650
19,989,709
—
—
19,993,359
Common stock issued for commitment shares
112,739
113
673,465
—
—
673,578
Common stock sales at the market by investment banking company
202,115
202
1,515,676
—
—
1,515,878
Exercise of options
914,408
914
776,760
—
—
777,674
Exercise of warrants
269,000
269
235,981
—
—
236,250
Options issued for services
—
—
6,459,387
—
—
6,459,387
Restricted stock awards issued for future services
105,854
106
561,560
( 561,666 )
—
—
Deferred compensation
—
—
—
262,697
—
262,697
Net loss for the year ended December 31, 2023
—
—
—
—
( 21,038,032 )
( 21,038,032 )
BALANCE AT DECEMBER 31, 2023
118,137,309
$ 118,137
$ 164,619,363
$ ( 432,293 )
$ ( 127,871,393 )
$ 36,433,814
The accompanying
notes are an integral part of these financial statements.
F- 8
LIGHTWAVE LOGIC, INC.
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023
2024
2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$ ( 22,535,041 )
$ ( 21,038,032 )
Adjustments to reconcile net loss to net cash used in operating activities
Stock options issued for services
4,440,003
6,459,387
Amortization of deferred compensation
446,628
262,697
Common stock issued for commitment shares
154,210
673,578
Depreciation and amortization of patents
1,682,760
1,119,141
Amortization of right of use asset
192,487
184,835
Loss (gain) on disposal of property and equipment and intangible assets
213,440
( 215,509 )
Decrease (increase) in assets
Accounts receivable
( 15,189 )
( 30,376 )
Prepaid expenses and other current assets
835,880
( 587,540 )
(Decrease) increase in liabilities
Accounts payable
( 931,641 )
655,925
Accrued bonuses, accrued expenses and other liabilities
277,735
219,150
Accounts payable and accrued expenses-related parties
( 112,704 )
213,314
Contract liability
( 16,667 )
39,875
Deferred lease liability
( 38,297 )
( 41,778 )
Operating lease liability
( 144,119 )
( 150,691 )
Net cash used in operating activities
( 15,550,515 )
( 12,236,024 )
CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles
( 430,501 )
( 307,687 )
Purchase of property and equipment
( 2,267,398 )
( 3,292,224 )
Repayment of loan
—
642,120
Sale of property and equipment
—
590
Net cash used in investing activities
( 2,697,899 )
( 2,957,201 )
CASH FLOWS FROM FINANCING ACTIVITIES
Exercise of options and warrants
337,350
1,013,924
Issuance of common stock, institutional investor
12,366,965
19,993,359
Common stock sales at the market by investment banking company
1,779,976
1,515,878
Net cash provided by financing activities
14,484,291
22,523,161
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
( 3,764,123 )
7,329,936
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR
31,432,087
24,102,151
CASH AND CASH EQUIVALENTS - END OF YEAR
$ 27,667,964
$ 31,432,087
Supplemental Disclosure of Non-cash investing and financing activities :
Amended Operating Lease - Right of Use - Building and Operating lease liability
$ —
$ 2,703,527
The
accompanying notes are an integral part of these financial statements.
F- 9
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND
2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
History and
Nature of Business
Lightwave Logic, Inc is a technology platform
company leveraging its proprietary engineered electro-optic (EO) polymers, named Perkinamine® to transmit data at higher speeds with
less power in a small form factor. The Company’s high activity and high stability organic polymers allow it to create next-generation
photonic EO devices that convert data from electrical signals into light/optical signals for applications in telecommunications, and
for data transmission potentially used to support generative AI.
The
Company's first revenue stream is from a technology material supply and licensing agreement that incorporates the Company's patented
electro-optic polymer materials for use in manufacturing photonic devices. Currently, the Company is in various stages of materials development
and evaluation with potential customers and strategic partners. The Company expects to continue to obtain a revenue stream from technology
licensing agreements, and to obtain additional revenue streams from technology transfer agreements and direct sale of its electro-optic
materials.
The Company’s current
development activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize
the Company’s technology now under development.
Lightwave Logic, Inc. was organized under the laws
of the State of Nevada in 1997, and it commenced with its current business plan in 2004.
Basis of Presentation
The accompanying financial statements are presented
in accordance with accounting principles generally accepted in the United States of America.
Estimates
The preparation of financial statements in conformity
with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the
amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best
knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates.
Cash Equivalents
The Company considers all highly liquid investments
with an original maturity from the date of purchase of three months or less to be cash equivalents.
Concentration
of Credit Risk
Certain financial instruments potentially subject
the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2024, the Company
did have deposits with a financial institution that exceed the Federal Depository Insurance coverage.
Accounts Receivable
Accounts receivable are carried at their contractual amounts, less an estimated
allowance for credit losses. Management estimates the allowance for credit losses using a loss-rate approach based on historical loss
information, adjusted for management’s expectations about current and future economic conditions, as the basis to determine expected
credit losses. Management exercises significant judgment in determining expected credit losses. Key inputs include macroeconomic factors,
industry trends, the creditworthiness of counterparties, historical experience, the financial conditions of the customers, and the amount
and age of past due accounts. Management believes that the composition of receivables at year-end is consistent with historical conditions
as credit terms and practices and the client base has not changed significantly. Receivables are considered past due if full payment is
not received by the contractual due date, which is typically 30 days from the invoice date. Past due accounts are generally written off
against the allowance for credit losses only after all collection attempts have been exhausted. The allowance for credit losses was zero
0 as of December 31, 2024 and 2023.
There was one customer who represented 100 % of total accounts receivable
as of December 31, 2024.
F- 10
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)
Property and Equipment
Property and equipment is stated at the Company’s original cost or
fair value for acquired property and equipment net of accumulated depreciation. Depreciation of property and equipment is computed using
the straight-line method over the estimated useful lives of the respective assets, which are generally as follows: 3 years for office
equipment, 3 to 5 years for lab equipment, 7 years for furniture and 3 years for software. Leasehold improvements are amortized over the
lesser of remaining life of the lease or. Leasehold improvements are amortized over the lesser of remaining life of the lease or useful
life of the asset, using the straight-line method. The cost of normal maintenance and repairs is charged to operating expenses as incurred.
Material expenditures that increase the life of an asset are capitalized and depreciated over the estimated remaining useful life of the
asset. The cost of assets sold, or otherwise disposed of, and the related accumulated depreciation is relieved from the property accounts,
and any gains or losses are recognized in income from continued operations.
Intangible Assets
Definite-lived intangible assets are stated at cost.
Patents are amortized over their estimated useful lives, commencing from the date of grant for the remaining legal lives of the patents.
The patents generally have a term of up to 20 years from the date of filing of the earliest related patent application. When certain patent
applications are abandoned by the Company for claims that are covered by patents already granted to the Company, the cost of patent applications
are removed from the accounts and the resulting expense is reflected in the statement of comprehensive loss.
Fair Value of Financial Instruments
The carrying value of the Company’s short-term
financial instruments such as cash, accounts payable and accrued expenses approximate their fair values because of their short maturities.
Revenue Recognition and Contract Liability
The Company recognizes revenue in accordance with
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from
Contracts with Customers. Under ASC 606, revenue is recognized when control of goods or services is transferred to a customer in an amount
that reflects the consideration to which the Company expects to be entitled.
To achieve this, the Company applies the five-step
model:
1. Identify the contract with a customer.
2. Identify the performance obligations in the contract.
3. Determine the transaction price for the contract.
4. Allocate the transaction price to the performance obligations.
5. Recognize revenue as performance obligations are satisfied.
The Company’s primary revenue stream includes technology license
and material supply agreements.
F- 11
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)
Revenue Recognition and Contract Liability (Continued)
Technology License and Material Supply Agreements
The Company enters into technology license and material
supply agreements, under which it grants customers a non-exclusive, royalty-bearing license to use its patented electro-optic polymer
technology (the “Licensed Product”). The Company also supplies proprietary polymers to licensees for use in their manufacturing
of photonic devices.
The Company assesses whether the license and the
supply of proprietary polymers represent distinct performance obligations. Based on this assessment, the Company has determined that the
license and material supply are not distinct for financial reporting purposes because they are highly interdependent. Accordingly, the
Company accounts for these as a single performance obligation.
Revenue under these agreements is recognized as follows:
Upfront License Fees – Nonrefundable upfront
license fees are recorded as contract liability and recognized on a pro-rata basis over the contract term.
Minimum Annual Royalties – Fixed royalty payments
required under the contract are also recognized on a pro-rata basis over the contract term.
Variable Royalties – Royalties exceeding the
minimum annual amount are recognized when earned, typically when the licensee’s sales exceed the minimum threshold.
Milestone Payments – Recognized only when the
contractual milestone is achieved, such as when the licensee sells a specified number of units of the Licensed Product.
Contract Costs
The Company capitalizes incremental costs to obtain
contracts if they are expected to be recoverable, in accordance with ASC 340-40, Other Assets and Deferred Costs – Contracts with
Customers. These capitalized costs are amortized over the expected contract term in a manner consistent with the related revenue recognition.
Contract Liability
Contract liability represents amounts received in
advance for performance obligations not yet satisfied, including nonrefundable upfront license fees. The Company recognizes contract liability
revenue as revenue when the related performance obligations are satisfied.
Cost of Sales
Cost of sales consists of labor costs, material costs and manufacturing
overhead costs associated with the production of materials transferred to the customer under the technology license and material supply
agreement at the Company’s facility.
F- 12
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)
Income Taxes
The Company follows FASB ASC 740, “Income Taxes,”
which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and
liabilities are computed annually for temporary differences between the financial statement and tax bases of assets and liabilities that
will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the
differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to
the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during
the period in deferred tax assets and liabilities.
Stock-based Payments
The Company
accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation", which
requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated
fair values on the grant date. The fair value of restricted stock awards is estimated by the market price of the Company’s common
stock at the date of grant. Restricted stock awards are being amortized to expense over the shorter of the requisite service period or
the actual vesting period. The Company estimates the fair value of option and warrant awards on the date of grant using the Black-Scholes
model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the requisite
service period or the actual vesting period, using the straight-line method. In June 2018, the FASB issued Accounting Standard Update
(“ASU”) No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based
Payment Accounting (the “2018 Update). The amendments in the 2018 Update expand the
scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Prior to the 2018
Update, Topic 718 applied only to share- based transactions to employees. Consistent with the accounting requirement for employee share-based
payment awards, nonemployee share-based payment awards within the scope of Topic 718 are measured at grant-date fair value of the equity
instruments that an entity is obligated to issue when the good has been delivered or the service has been rendered and any other conditions
necessary to earn the right to benefit from the instruments have been satisfied.
The Company has
elected to account for forfeiture of stock-based awards as they occur.
Loss Per Share
The Company follows
FASB ASC 260, “Earnings per Share”, resulting in the presentation of basic and diluted earnings per share. Because the Company
reported a net loss in 2024 and 2023, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the
amounts reported for basic and dilutive loss per share were the same.
Leases
The Company is a lessee in operating
leases primarily incurred to facilitate manufacturing, research and development, and selling, general and administrative activities. At
contract inception, the Company determines if an arrangement is or contains a lease, and if so, recognizes a right-of-use asset and lease
liability at the lease commencement date. For operating leases, the lease liability is measured at the present value of the unpaid lease
payments at the lease commencement date, whereas for finance leases, the lease liability is initially measured at the present value of
the unpaid lease payments and subsequently measured at amortized cost using the interest method. Operating lease right-of-use assets are
included in other assets on the Balance Sheets. The short-term portion of operating lease liabilities is included in other current liabilities
on the Balance Sheets and the long-term portion is included in long term liabilities on the Balance Sheets. As of December 31, 2024, the
Company had no leases that qualified as financing arrangements.
F- 13
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)
Leases (Continued)
Key estimates and judgments
include how the Company determines the discount rate used to discount the unpaid lease payments to present value and the lease term. The
Company monitors for events or changes in circumstances that could potentially require recognizing an impairment loss.
The Company elected a short-term
lease exemption practical expedient under ASU 2026-02, “Leases” (Topic 842), which allows the Company to not recognize leases
with the total lease term of 12 months or less on the balance sheet.
Impairment of Long Lived and Finite-Lived Intangible Assets
Long lived assets, such as property,
equipment, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate
that the carrying amount of an asset group may not be recoverable, such as a significant decrease in market price of an asset group, a
significant adverse change in legal factors or business climate that could affect the value of an asset group, or a continuous deterioration
of the Company’s financial condition. Recoverability of asset groups to be held and used is measured by comparing the undiscounted
future cash flows expected to be generated by the asset group to the carrying amount of the asset group. If the carrying amount of the
asset group exceeds its estimated undiscounted future cash flows, impairment is recognized to the extent that the carrying value exceeds
its fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values,
and third-party independent appraisals, as considered necessary.
For the years ended December
31, 2024 and 2023, the Company did no t record an impairment of its long-lived and finite-lived intangible assets.
Comprehensive
Loss
The Company
follows FASB ASC 220.10, “Reporting Comprehensive Income (Loss).” Comprehensive loss is a more inclusive financial reporting
methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of
net loss. Since the Company has no items of other comprehensive loss, comprehensive loss is equal to net loss.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting
(Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose significant segment expenses
and other segment items on an interim and annual basis and provide in interim periods all disclosures about a reportable segment's profit
or loss and assets that are currently required annually. The ASU does not change how a public entity identifies its operating segments,
aggregates them, or applies the quantitative threshold to determine its reportable segments. The new disclosure requirements are also
applicable to entities that account and report as a single operating segment entity. ASU 2023-07 is effective for fiscal years beginning
after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company adopted the guidance
for the annual reporting period ended December 31, 2024. There was no impact on the Company’s reportable segments identified and
additional required disclosures have been included in Note 14 - Segment Reporting.
Recently Issued Accounting Pronouncements Not Yet
Adopted
ASU 2023-09 – Income Taxes
(Topic 740) requires disclosures related to the rate reconciliation and income taxes paid disclosures improve the transparency of income
tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income
taxes paid disaggregated by jurisdiction. The other amendments in this Update improve the effectiveness and comparability of disclosures
by (1) adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with U.S. Securities and Exchange
Commission (SEC) Regulation S-X 210.4-08(h), Rules of General Application—General Notes to Financial Statements: Income Tax Expense,
and (2) removing disclosures that no longer are considered cost beneficial or relevant. For public business entities, the amendments in
this Update are effective for annual periods beginning after December 15, 2024. The Company does not expect this ASU to have material
impact on its disclosures in the year of adoption.
F- 14
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)
Recently Issued Accounting Pronouncements Not
Yet Adopted (Continued)
ASU 2024-03 – Income Statement –
Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) requires disclosure, in the notes to
financial statements, of specified information about certain costs and expenses, such as the amounts of purchases of inventory,
employee compensation, depreciation, intangible asset amortization, included in each relevant expense caption; disclosure of a
qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively;
and disclosure of the total amounts of selling expenses. For public business entities, the amendments in this Update are effective
for annual periods beginning after December 15, 2026 and interim reporting period within fiscal years beginning after December 15,
2027. Early adoption is permitted. The Company is evaluating the impact of this ASU on its financial statement disclosures.
NOTE 2 – MANAGEMENT’S PLANS
The Company’s future expenditures and capital
requirements will depend on numerous factors, including: the progress of our research and development efforts; the rate at which the
Company can, directly or through arrangements with original equipment manufacturers, introduce and sell its polymer materials technology;
the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance
of the Company’s products and competing technological developments; and the Company’s ability to establish cooperative development,
joint venture and licensing arrangements. The Company expects that it will incur approximately $ 1,727,000 of
expenditures per month over the next 12 months. The Company’s current cash position enables it to finance its operations through
April 2026. On March 17, 2025, the Company entered into a purchase agreement with an institutional investor to sell up to $ 30,000,000
of common stock over a 36-month period. As of the date of this filing, $ 30,000,000
remains available to the Company per the agreement. On February 28, 2023, the Company entered into a purchase agreement
with an institutional investor to sell up to $ 30,000,000
of common stock over a 36-month period (described in Note 10). Pursuant to the purchase agreement, the Company received $ 1,486,983
during the period from January 1 through March 18, 2025 and the remaining available amount of $ 0
is available to the Company per the agreement. On December 9, 2022, the Company entered into a sales agreement with an investment
banking company whereby the Company may offer and sell shares of its common stock having an aggregate offering price of up to $ 35,000,000
from time to time through or to the investment banking company, as sales agent or principal (described in Note 10). Pursuant to
the sales agreement, the Company received $ 116,435
during the period from January 1 through March 18, 2025 and the remaining available amount of $ 31,482,032
is available to the Company per the agreement. The Company's first commercial agreement occurred in May 2023 from a material supply
and license agreement that incorporates the Company's patented electro-optic polymer materials for use in manufacturing photonic devices
(described in Note 3). For the year ended December 31, 2024, the Company recognized $ 81,855
in revenue related to this agreement. The Company’s cash requirements are expected to increase at a rate consistent with
the Company’s path to revenue as it expands its activities and operations with the objective of increasing its revenue stream from
commercialization of its electro-optic polymer technology. The Company currently has no debt to service.
NOTE 3 – REVENUE
The Company's first commercial agreement occurred in May 2023, in the form
of a four-year material supply and license agreement (the “License Agreement”) that incorporates the Company's patented
electro-optic polymer materials for use in manufacturing of photonic devices (the “Licensed Product”). The licensee shall
pay the Company a running royalty with a minimum royalty paid on an annual basis over the term of the License Agreement the minimum royalty
payments and milestone license fees. The License Agreement is a non-exclusive material supply and license agreement.
F- 15
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 3 – REVENUE (CONTINUED)
Additional future revenue will be
generated from royalties from the licensee’s sale of Licensed Product that exceed the minimum royalty payments and milestone
license fees.
During 2024, the Company also performed device processing
work for a customer.
Timing of Revenue Recognition and Contract Balances
Revenues related
to the initial license fee and a minimum annual royalty are recognized over time commencing with the License Agreement in May 2023. An
up-front license fee in the amount of $ 50,000 was paid during the period ended December 31, 2023. $ 23,208 and $ 39,875 of this amount is
recorded as a contract liability in current liabilities on the Company’s balance sheets as of December 31, 2024 and December 31,
2023, respectively. For the years ended December 31, 2024 and December 31, 2023, the Company recognized
$ 81,855 and $ 40,502 in revenue related to this agreement.
In March 2024, the Company completed device processing
work on the devices supplied by a customer. Revenue for this contract was recognized at the time of shipment of the devices back to the
customer and amounted to $ 13,750 for the year ended December 31, 2024.
Contract balances
are as follows:
Schedule of contract balances
December
31, 2024
December
31, 2023
Accounts receivable, net
$ 45,565
$ 30,376
Short-term contract assets
$ —
$ —
Long-term contract assets
$ —
$ —
Short-term contract liability
$ 23,208
$ 39,875
Significant changes in the contract balances
for the years ended December 31, 2024 are as follows:
Schedule of significant changes in the contract balances
Year Ended December 31, 2024
Assets
Liabilities
Balance at December 31, 2023
$ 30,376
$ ( 39,875 )
Revenue recognized that was previously included in contract liability
—
16,667
Decreases/increases due to cash received
( 63,884 )
—
Billed receivables recorded
109,449
—
Transferred to receivables from unbilled receivables
( 95,564 )
—
Unbilled receivables recorded
65,188
—
Balance at December 31, 2024
$ 45,565
$ ( 23,208 )
A rollforward of contract balances is
not disclosed for the year ended December 31, 2023 since there were no contracts as of December 31, 2022.
Assets Recognized for the Costs to
Obtain a Contract
There are no assets recognized for the
costs to obtain the License Agreement.
F- 16
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 4 – PREPAID EXPENSES AND OTHER CURRENT
ASSETS
Prepaid expenses and other current assets consist of the following:
Schedule of prepaid expenses and other current assets
December 31, 2024
December 31, 2023
Insurance
$ 154,945
$ 237,791
License
151,451
241,936
Prototype devices
44,134
161,267
Rent
36,525
36,525
Other
9,415
53,373
Investor relations
5,271
6,313
Materials fabrication
—
475,936
Deposit for equipment
—
20,000
Lease incentive receivable
—
4,480
Prepaid expenses and other current assets
$ 401,741
$ 1,237,621
NOTE 5 –
LOAN RECEIVABLE
On September 7, 2022, the Company entered into a
convertible loan agreement (the “Loan”) with an entity and issued a loan on September 12, 2022 in the amount of EUR 600,000
bearing interest at 7 % per annum with a maturity date of March 31, 2023 . The Company recorded $ 13,375 of interest income for the year
ended December 31, 2022. The exchange rates used for the conversion of the EUR denominated loan were the December 31, 2022 reporting
period end date exchange rate for the loan principal resulting in a balance of $ 642,120 and interest receivable resulting in a balance
of $ 13,669 and the average exchange rate for the period ended December 31, 2022 for interest income. The loan and interest were repaid
in February and March 2023. The Company recorded $ 11,125 of interest income for the period ended December 31, 2023 and used the average
exchange rate for the conversion of the EUR denominated interest income for the period.
F- 17
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 6 – PROPERTY AND EQUIPMENT
Property and equipment consist of the following:
Schedule of property and equipment
December 31, 2024
December 31, 2023
Office equipment
$ 155,511
$ 146,196
Lab equipment
10,953,487
8,937,847
Furniture
54,493
74,119
Leasehold improvements
432,400
396,111
Software
133,377
111,077
11,729,268
9,665,350
Less: Accumulated depreciation
6,037,723
4,674,560
$ 5,691,545
$ 4,990,790
Depreciation expense for the years ended December
31, 2024 and 2023 was $ 1,563,477 and $ 1,035,620 , respectively. During the year ended December 31, 2024, the Company retired property and
equipment with a cost of $ 203,480 and accumulated depreciation of $ 200,314 for a loss of $ 3,166 . During the year ended December 31, 2023,
the Company disposed of equipment for proceeds of $ 590 , trade-in credit of $ 216,090 and a gain of $ 215,509 .
NOTE 7 – INTANGIBLE ASSETS
Intangible assets represent legal fees and patent
fees associated with the prosecution of patent applications. The Company has recorded amortization expense on patents granted, which
are amortized over the remaining legal life. Maintenance patent fees are paid to a government patent authority to maintain a granted patent in
force. Some countries require the payment of maintenance fees for pending patent applications. Maintenance fees paid after a patent
is granted are expensed, as these are considered ongoing costs to “maintain a patent”. Maintenance fees paid prior to
a patent grant date are capitalized to patent costs, as these are considered “patent application costs”. No amortization expense
has been recorded on the remaining patent applications since patents on these applications have yet to be granted.
Intangible assets consist of the following:
Schedule of intangible assets
December 31, 2024
December 31, 2023
Patents
$ 2,127,076
$ 1,913,751
Less: Accumulated amortization
771,631
659,250
Intangible assets - net
$ 1,355,445
$ 1,254,501
Amortization expense for the years ended
December 31, 2024 and 2023 was $ 119,283
and $ 83,521 ,
respectively. During the year ended December 31, 2024, the Company retired certain expired patent applications and patents with a
cost of $ 217,176 and
accumulated amortization of $ 6,902
for a loss of $ 210,274
included in the statements of comprehensive loss in the (Loss) gain on disposal of property and equipment and intangible assets.
There were no
patent costs written off for the year ended December 31, 2023.
F- 18
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 8 – LEASES
On October 30, 2017, the Company entered into a lease
agreement (the “Lease”) to lease approximately 13,420 square feet of office, chemistry, clean room and research and development
space located in Colorado for the Company’s principal executive offices and research and development facility. The term of
the lease is sixty-one ( 61 ) months, beginning on November 1, 2017 and ending on November 30, 2022 . In January 2022, the term was
extended for an additional twenty-four ( 24 ) months.
On November 22, 2022, the Company entered into an
amendment to the Lease (“the Amended Lease”) to lease an additional approximately 9,684 square feet of adjacent office and
warehouse space. The term of the Amended Lease is one hundred twenty ( 128 ) months, with an effective date of June 1, 2023 . Base
rent through January 31, 2024 of the Amended Lease term is approximately $ 30,517 per month. The base rent for the next full year of the
Amended Lease term is approximately $ 377,288 , with an increase in annual base rent of approximately 3 % in each subsequent year of the
lease term. Commencing on June 1, 2023, monthly installments of base rent and one-twelfth of landlord’s estimate of tenant’s
proportionate share of annual operating expenses shall be due on the first day of each calendar month. The Amended Lease also provides
an allowance of up to $ 43,216 to be used solely for the cost of renovations to the additional lease premises. As of June 1, 2023, the
operating lease right-of-use asset and operating lease liability amounted to $ 2,945,322 and $ 2,984,058 , respectively. As of December 30,
2024, the operating lease right-of-use asset and operating lease liability amounted to $ 2,645,723 and $ 2,766,971 , respectively.
For purposes of calculating operating lease liability,
lease term includes the initial non-cancelable term plus any term under renewal options that are reasonably assured. Any rent escalations,
along with rent abatements, are included in the computation of rent expense calculated on a straight-line basis over the lease term. The
interest rate implicit in lease contracts is typically not readily determinable and as such the Company uses the appropriate incremental
borrowing rate based on information available at the lease commencement date in determining the present value of the lease payments.
Undiscounted future minimum lease payments under
the Amended Lease as of December 31, 2024, by year and in aggregate, including the extended term, are as follows:
Schedule of future lease payments of operating leases
YEARS ENDED
DECEMBER 31,
AMOUNT
2025
387,666
2026
399,199
2027
411,174
2028
423,612
2029
436,300
Thereafter
1,921,271
3,979,222
Less discounted interest
( 1,212,251 )
TOTAL
$ 2,766,971
The Company has elected not to recognize right-of-use
assets and lease liabilities arising from short-term leases. There are no other material operating leases.
The following table presents weighted average assumptions
used to compute the Company’s right-of-use assets and lease liabilities:
Schedule of operating lease right-of-use assets
December 31, 2024
Weighted average remaining lease term (in years)
9.08
Weighted average discount rate
8.25 %
As of December 31, 2024, current operating leases
had remaining terms between 13 months and 9 years, with some leases having options to extend the lease terms.
Current lease agreements do not contain any residual
value guarantees or material restrictive covenants. As of December 31, 2024, the Company did not have any finance leases.
Operating and short-term lease costs totaling $ 513,428
and $ 102,077 are included in research and development and general and administrative expenses for the year ended December 31, 2024. Operating
and short-term lease costs totaling $ 334,051 and $ 79,083 are included in research and development and general and administrative expenses
for the year ended December 31, 2023.
F- 19
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 9 – INCOME TAXES
As
discussed in Note 1, the Company utilizes the asset and liability method of accounting for income taxes in accordance with FASB ASC 740.
The
income tax (benefit) provision consists of the following:
Schedule of income tax benefit provision
2024
2023
Current
$ —
$ —
Deferred
( 4,220,000 )
( 6,526,000 )
Change in valuation allowance
4,220,000
6,526,000
Total
$ —
$ —
The reconciliation of the statutory federal rate to the Company’s
effective income tax rate is as follows:
Schedule of reconciliation of statutory federal rate to effective income tax rate
2024
2023
Amount
%
Amount
%
Income tax benefit at U.S. federal income tax rate
$ ( 4,732,000 )
( 21 )
$ ( 4,418,000 )
( 21 )
State tax benefit, net of federal tax effect
( 763,000 )
( 3 )
( 957,000 )
( 5 )
Federal deduction net of tax
—
—
44,000
—
Non-deductible share-based compensation
—
—
1,653,000
8
Exercised share based compensation
( 280,000 )
( 1 )
( 2,850,000 )
( 13 )
Other
1,555,000
6
2,000
—
Change in valuation allowance
4,220,000
19
6,526,000
31
$ —
—
$ —
—
The components of deferred tax assets as of December 31, 2024 and 2023
are as follows:
Schedule of components of deferred tax assets
2024
2023
Deferred tax asset for NOL carryforwards
$ 29,737,000
$ 29,018,000
Share-based compensation
4,901,000
3,889,000
Section 174 research and development expenses
4,932,000
—
Section 481(a) adjustment
( 2,264,000 )
—
Other
( 281,000 )
( 102,000 )
Valuation allowance
( 37,025,000 )
( 32,805,000 )
Total
$ —
$ —
The valuation allowance for deferred tax assets as
of December 31, 2024 and 2023 was $ 37,025,000 and $ 32,805,000 , respectively. The change in the total valuation for the year ended December
31, 2024 was an increase of $ 4,220,000 , and for the year ended December 31, 2023 was an increase of $ 6,526,000 . In assessing the realization
of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the
periods in which the net operating losses and temporary differences become deductible. Management considered projected future taxable
income and tax planning strategies in making this assessment. The value of the deferred tax assets was offset by a valuation allowance,
due to the current uncertainty of the future realization of the deferred tax assets.
F- 20
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 9 – INCOME TAXES (CONTINUED)
As of December 31, 2024, the Company had net operating
loss carry forwards of approximately $ 121,349,000 , comprised of net operating losses in the amount of approximately $ 36,485,000 recorded
in tax years beginning prior to January 1, 2018 expiring through the year ending December 31, 2038 and net operating losses recorded in
tax years beginning January 1, 2018 and after in the amount of approximately $ 84,864,000 which are allowed for an indefinite carryforward
period but may be subject to limitations. This amount can be used to offset future taxable income of the Company.
The timing and manner in which the Company can utilize
operating loss carryforwards in any year may be limited by provisions of the Internal Revenue Code regarding changes in ownership of corporations.
Such limitation may have an impact on the ultimate realization of its carryforwards and future tax deductions.
The Company follows ASC 740-10, which provides guidance
for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination
of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position
will be examined by the appropriate taxing authority having full knowledge of all relevant information. The adoption of ASC 740-10 did
not require an adjustment to the Company’s financial statements.
The Company’s policy is to record interest and
penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2024,
the Company had no unrecognized tax benefits and no charge during 2024, and accordingly, the Company did no t recognize any interest or
penalties during 2024 related to unrecognized tax benefits. There is no accrual for uncertain tax positions as of December 31, 2024.
The Company files U.S. income tax returns and a state
income tax return. With few exceptions, the U.S. and state income tax returns filed for the tax years ended on December 31, 2021 and
thereafter are subject to examination by the relevant taxing authorities.
NOTE 10 – STOCKHOLDERS’ EQUITY
Preferred
Stock
Pursuant to the Company’s Articles of
Incorporation, the Company’s board of directors is empowered, without stockholder approval, to issue series of preferred stock
with any designations, rights and preferences as they may from time to time determine. The rights and preferences of this preferred stock
may be superior to the rights and preferences of the Company’s common stock; consequently, preferred stock, if issued could have
dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common
stock. Additionally, preferred stock, if issued, could be utilized, under special circumstances, as a method of discouraging, delaying
or preventing a change in control of the Company’s business or a takeover from a third party.
Common Stock
On July 2, 2021, the Company filed a
$100,000,000 universal shelf registration statement with the U.S. Securities and Exchange Commission which became effective on July 9,
2021 and expired on July 8, 2024.
On July 26, 2024, the Company filed a new $100,000,000
universal shelf registration statement with the U.S. Securities and Exchange Commission which became effective on August 5, 2024.
F- 21
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 10 – STOCKHOLDERS’ EQUITY (CONTINUED)
Common Stock (Continued)
On October 4, 2021, the Company entered
into a purchase agreement with an institutional investor to sell up to $ 33,000,000 of common stock over a 36-month period. Concurrently
with entering into the purchase agreement, the Company also entered into a registration rights agreement which provides the institutional
investor with certain registration rights related to the shares issued under the purchase agreement. Pursuant to the purchase agreement,
the Company issued 30,312 shares of common stock to the institutional investor as an initial commitment fee valued at $ 279,174 , fair
value, and 60,623 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with
the terms of the purchase agreement. During the period October 4, 2021 through December 31, 2023, the institutional investor purchased
3,632,456 shares of common stock for proceeds of $ 33,000,000 and the Company issued 60,623 shares of common stock as additional commitment
fee, valued at $ 694,531 fair value. During the year ended December 31, 2023, pursuant to the purchase agreement, the institutional investor
purchased 779,945 shares of common stock for proceeds of $ 3,847,307 and the Company issued 7,069 shares of common stock as additional
commitment fee, valued at $ 38,161 fair value. All of the registered shares under the purchase agreement have been issued as of December
31, 2023.
On February 28, 2023, the Company entered into a
purchase agreement with an institutional investor to sell up to $ 30,000,000
of common stock over a 36-month period. Concurrently with entering into the purchase agreement, the Company also entered into
a registration rights agreement which provides the institutional investor with certain registration rights related to the shares issued
under the purchase agreement. Pursuant to the purchase agreement, the Company issued 50,891
shares of common stock to the institutional investor as an initial commitment fee valued at $ 279,391 ,
fair value, and 101,781
shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms
of the purchase agreement. During the period February 28, 2023 through December 31, 2024, the institutional investor purchased 6,720,455
shares of common stock for proceeds of $ 28,513,017
and the Company issued 96,735
shares of common stock as additional commitment fee, valued at $ 510,236
fair value, leaving 5,046
in reserve for additional commitment fees. During the year ended December 31, 2024, pursuant to the purchase agreement, the institutional
investor purchased 3,850,000
shares of common stock for proceeds of $ 12,366,965 ,
and the Company issued 41,956
shares of common stock as additional commitment fee, valued $ 154,210
fair value. During the period February 28, 2023 through December 31, 2023, the institutional investor purchased 2,870,455
shares of common stock for proceeds of $ 16,146,052
and the Company issued 54,779
shares of common stock as additional commitment fee, valued at $ 356,026
fair value. During the period from January 1, 2025 through March 18, 2025, pursuant to the purchase agreement, the institutional
investor purchased 1,035,881
shares of common stock for proceeds of $ 1,486,983
and the Company issued 5,046
shares of common stock as additional commitment fee, valued at $ 8,029
fair value, leaving zero 0
in reserve for additional commitment fees.
On December 9, 2022, the Company entered into a sales agreement with an
investment banking company. In accordance with the terms of this sales agreement, the Company may offer and sell shares of its common
stock having an aggregate offering price of up to $ 35,000,000 from time to time through or to the investment banking company, as sales
agent or principal. Sales of shares of the Company’s common stock, if any, may be made by any method deemed to be an “at the
market offering”. The sales agent is entitled to compensation under the terms of the sales agreement at a commission rate equal
to 3 % of the gross proceeds of the sales price of common stock that they sell.
F- 22
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 11 – STOCK BASED COMPENSATION
Common Stock (Continued)
During the year ended December 31, 2024, pursuant
to the sales agreement, the investment banking company sold 551,501
shares of the Company’s common stock for proceeds of $ 1,779,976
after a payment of the commission in the amount of $ 55,054
to the investment banking company. During the year ended December 31, 2023, pursuant to the sales agreement, the investment banking
company sold 202,115
shares of the Company’s common stock for proceeds of $ 1,515,878
after a payment of the commission in the amount of $ 46,884
to the investment banking company. During the period from January 1, 2025 through March 18, 2025, pursuant to the sales agreement,
the investment banking company sold 50,000
shares of the Company’s common stock for proceeds of $ 116,435
after a payment of the commission in the amount of $ 3,601
to the investment banking company.
Common Stock Options and Warrants
During 2007, the Board of Directors
of the Company adopted the 2007 Employee Stock Plan (“2007 Plan”) that was approved by the shareholders. Under the 2007 Plan,
the Company is authorized to grant options to purchase up to 10,000,000 shares of common stock to directors, officers, employees and
consultants who provide services to the Company. The 2007 Plan is intended to permit stock options granted to employees under the 2007
Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock
Options”). All options granted under the 2007 Plan, which are not intended to qualify as Incentive Stock Options are deemed to
be non-qualified options (“Non-Statutory Stock Options”).
Effective June 24, 2016, the 2007 Plan was terminated.
As of December 31, 2024, options to purchase 2,053,000 shares of common stock have been issued and are outstanding.
During 2016, the Board of Directors of the Company
adopted the 2016 Plan that was approved by the shareholders at the 2016 annual meeting of shareholders on May 20, 2016. Under the 2016
Plan, the Company is authorized to grant awards of incentive and non-qualified stock options and restricted stock to purchase up to 3,000,000
shares of common stock to employees, directors and consultants. Effective May 16, 2019, the number of shares of the Company’s common
stock available for issuance under the 2016 Plan was increased from 3,000,000 to 8,000,000 shares. Effective May 25, 2023, the number
of shares of the Company’s common stock available for issuance under the 2016 Plan was increased from 8,000,000 to 13,000,000 shares
and awards of restricted stock units are authorized for issuance. As of December 31, 2024, options to purchase 7,446,859 shares of common
stock have been issued and are outstanding and 356,061 restricted shares of common stock have been granted. As of December 31, 2024, 3,480,845
shares of common stock remain available for grants under the 2016 Plan.
F- 23
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 11 – STOCK BASED COMPENSATION (CONTINUED)
Common Stock Options and Warrants (Continued)
Both plans are administered by the Company’s
Board of Directors or its compensation committee which determines the persons to whom awards will be granted, the number of awards to
be granted, and the specific terms of each grant. Subject to the provisions regarding Ten Percent Shareholders, (as defined in the 2016 Plan), the exercise
price per share of each option cannot be less than 100% of the fair market value of a share of common stock on the date of grant.
Options granted under the 2016 Plan are generally exercisable for a period of 10 years from the date of grant and may vest on the
grant date, another specified date or over a period of time.
The Company uses the Black-Scholes option pricing
model to calculate the grant-date fair value of an award, with the following assumptions for 2024: no dividend yield, expected volatility,
based on the Company’s historical volatility, 76.3 % to 78.5 % , risk-free interest rate between 3.73 % to 4.47 % and expected option
life of 10 years, which is based on the legal contractual life of the options.
The Black-Scholes option pricing model assumptions
for 2023 are as follows: no dividend yield, expected volatility, based on the Company’s historical volatility, 73.7 % to 77.2 % , risk-free
interest rate between 3.37 % to 4.82 % and expected option life of 10 years.
As of December 31, 2024, there was $ 2,755,783 of unrecognized
compensation expense related to non-vested market-based share awards that is expected to be recognized through December 2027. As of December
31, 2023, there was $ 3,295,335 of unrecognized compensation expense related to non-vested market-based share awards.
Share-based compensation was recognized as follows:
Schedule of share-based compensation
2024
2023
2007 Employee Stock Option Plan
$ —
$ —
2016 Equity Incentive Plan
4,440,003
6,459,387
2016 Equity Incentive Plan restricted stock awards
446,628
262,697
Warrants
—
—
Total share-based compensation
$ 4,886,631
$ 6,722,084
F- 24
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 11 – STOCK BASED COMPENSATION (CONTINUED)
Common Stock Options and Warrants (Continued)
The following tables summarize all stock option
and warrant activity of the Company during the years ended December 31, 2024 and 2023:
Schedule of stock option and warrant activity
Non-Qualified
Stock Options and Warrants Outstanding and Exercisable
Number
of
Exercise
Weighted
Average
Shares
Price
Exercise
Price
Outstanding, December 31, 2022
8,073,173
$ 0.51 - $ 16.81
$ 1.91
Granted
1,959,667
$ 4.28 - $ 7.67
$ 5.24
Forfeited
( 39,625 )
$ 6.25 - $ 8.93
$ 7.12
Exercised
( 1,183,408 )
$ 0.67 - $ 5.22
$ 0.86
Outstanding, December 31, 2023
8,809,807
$ 0.51 - $ 16.81
$ 2.76
Granted
1,628,000
$ 1.96 - $ 5.00
$ 4.05
Forfeited
( 43,948 )
$ 4.28 - $ 7.67
$ 5.70
Exercised
( 494,000 )
$ 0.57 - $ 1.15
$ 0.68
Outstanding, December 31, 2024
9,899,859
$ 0.51 - $ 16.81
$ 3.07
Exercisable, December 31, 2024
8,848,908
$ 0.51 - $ 16.81
$ 3.00
The aggregate intrinsic value of options and warrants outstanding and exercisable
as of December 31, 2024 was $ 6,418,443 and $ 6,400,033 , respectively. The aggregate intrinsic value is calculated as the difference between
the exercise price of the underlying options and warrants and the closing stock price of $ 2.10 for the Company’s common stock on
December 31, 2024. During the year ending December 31, 2024, 375,000 options with the aggregate intrinsic value of $ 1,399,958 were exercised
for proceeds of $ 246,100 . During the year ending December 31, 2024, 119,000 warrants with the aggregate intrinsic value of $ 171,550 were
exercised for proceeds of $ 91,250 . During the year ending December 31, 2023, 914,408 options with the aggregate intrinsic value of $ 4,698,996
were exercised for proceeds of $ 777,674 . During the year ending December 31, 2023, 269,000 warrants with the aggregate intrinsic value
of $ 1,162,230 were exercised for proceeds of $ 236,250 .
F- 25
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 11 – STOCK BASED COMPENSATION (CONTINUED)
Common Stock Options and Warrants (Continued)
Schedule of non-qualified stock options and warrants outstanding
Non-Qualified
Stock Options and Warrants Outstanding
Range of
Exercise Prices
Number Outstanding
Currently Exercisable
at December 31, 2024
Weighted Average
Remaining
Contractual Life
Weighted Average
Exercise Price of Options and
Warrants Currently Exercisable
$ 0.51 - $ 16.81
8,848,908
5.3 Years
$ 3.00
Restricted
Stock Awards
On March 16, 2023, the Compensation Committee of the
Board of Directors approved grants totaling 99,616 Restricted Stock Awards to the Company’s four outside directors. Each RSA had
a grant date fair value of $ 5.22 which shall be amortized on a straight-line basis over the vesting period into director’s compensation
expenses within the Statement of Comprehensive Loss. Such RSAs were granted under the 2016 Equity Incentive Plan (“2016 Plan”)
and vest in total 8,338 shares on March 16, 2023, with the remaining vesting in 33 equal monthly installments in total of 2,766 shares
beginning April 1, 2023.
On August 1, 2023, the Compensation Committee of the
Board of Directors approved a grant totaling 6,238 Restricted Stock Awards to the Company’s outside director. Each RSA had a grant
date fair value of $ 6.68 which shall be amortized on a straight-line basis over the vesting period into director’s compensation
expenses within the Statement of Comprehensive Loss. Such RSA was granted under the 2016 Plan. 218 shares from this grant vested on August
1, with the remaining vesting in 28 equal monthly installments in total of 215 shares beginning September 1, 2023.
On June 18, 2024, the Compensation Committee of the
Board of Directors approved grants totaling 92,475 Restricted Stock Awards to the Company’s five outside directors. Each RSA had
a grant date fair value of $ 3.33 which shall be amortized on a straight-line basis over the vesting period into director’s compensation
expenses within the Statement of Comprehensive Loss. Such RSAs were granted under the 2016 Equity Incentive Plan (“2016 Plan”)
and vested in total 15,455 shares on June 18, 2024, with the remaining vesting in 10 equal quarterly installments in total of 7,702 shares
beginning July 1, 2024.
On August 1, 2024, the Compensation Committee of the
Board of Directors approved a grant totaling 12,924 Restricted Stock Awards to the Company’s outside director. Each RSA had a grant
date fair value of $ 3.16 which shall be amortized on a straight-line basis over the vesting period into director’s compensation
expenses within the Statement of Comprehensive Loss. Such RSA was granted under the 2016 Equity Incentive Plan (“2016 Plan”)
and vests in 9 equal quarterly installments of 1,436 shares beginning September 1, 2024.
On September 4, 2024, the Compensation Committee of
the Board of Directors approved a grant totaling 11,488 Restricted Stock Awards to the Company’s outside director. Each RSA had
a grant date fair value of $ 2.68 which shall be amortized on a straight-line basis over the vesting period into director’s compensation
expenses within the Statement of Comprehensive Loss. Such RSA was granted under the 2016 Equity Incentive Plan
(“2016 Plan”) and vests in 8 equal quarterly installments of 1,436 shares beginning October 1, 2024.
F- 26
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 11 – STOCK BASED COMPENSATION (CONTINUED)
Restricted
Stock Awards (Continued)
On December 10, 2024, the Compensation Committee of
the Board of Directors approved a grant totaling 110,000 Restricted Stock Awards to the two Company’s executives and an outside
director for consulting services. Each RSA had a grant date fair value of $ 2.65 which shall be amortized on a straight-line basis over
the vesting period into stock-based compensation expenses within the Statement of Comprehensive Loss. The RSAs were granted under the
2016 Equity Incentive Plan (“2016 Plan”) and cliff vest on March 10, 2025 for an outside director and on June 10, 2025 for
the executives.
Upon the occurrence of a Change in Control, 100% of
the unvested Restricted Stock shall vest as of the date of the Change in Control. Upon vesting, the restrictions on the shares lapse.
The fair value of restricted stock awards is estimated
by the market price of the Company’s common stock at the date of grant. Restricted stock activity during the year ending December
31, 2024 and 2023 are as follows:
Schedule of fair value of restricted stock awards
Restricted Stock Awards
Year Ended
December 31, 2024
December 31, 2023
Number of
Shares
Weighted Average
Grant Date Fair
Value per Share
Number of
Shares
Weighted Average
Grant Date Fair
Value per Share
Non-vested, beginning of period
78,452
$ 5.71
13,816
$ 9.65
Granted
226,887
2.96
105,854
5.31
Vested
( 77,847 )
4.79
( 41,218 )
6.00
Cancelled and forfeited
—
—
—
—
Non-vested, end of period
227,492
$ 3.28
78,452
$ 5.71
Restricted stock awards are being amortized to expense
over the vesting period. As of December 31, 2024 and 2023, the unamortized value of the restricted stock awards was $ 656,735 and $ 432,292 ,
respectively.
NOTE 12 – RELATED PARTY
During the years ended December 31, 2024, and 2023,
the Company engaged in transactions with related parties, including consultants, directors, and entities affiliated with members of the
Board of Directors. These transactions primarily relate to legal services, consulting fees, director compensation, accounting services,
and expense reimbursements.
Related
Party Transactions for the Year Ended December 31, 2024
• The Company incurred $ 90,360
in legal fees with a related party law firm, of which $ 90,360
remained accrued as of December 31, 2024.
• The Company incurred $ 207,269 in accounting and
IT service fees and expense reimbursements to related parties, with $ 8,326 accrued as of December
31, 2024.
• The Company incurred $ 251,194 in fees and travel
expenses to directors, with $ 72,748 accrued as of December 31, 2024.
• The Company incurred $ 438,716 in consulting fees
and travel reimbursements to advisory board members, with $ 29,345 accrued as of December 31,
2024.
F- 27
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
NOTE 12 – RELATED PARTY (CONTINUED)
Related
Party Transactions for the Year Ended December 31, 2023:
• The
Company incurred $ 175,737 in legal fees with a related party law firm, of which $ 115,160 remained accrued as of December 31, 2023.
• The Company incurred
$ 382,910 in accounting and IT service fees and expense reimbursements to related parties, with $ 102,351 accrued as of December 31, 2023.
• The Company incurred $ 207,563 in fees and travel expenses to directors, with $ 62,226 accrued
as of December 31, 2023.
• The Company incurred $ 390,483 in consulting fees and travel reimbursements to advisory board
members, with $ 33,746 accrued as of December 31, 2023.
NOTE 13 – RETIREMENT PLAN
The Company established a 401(k)
retirement plan covering all eligible employees beginning November 15, 2013. The plan offers two types of elected deferrals: pre-tax
deferrals and Roth deferrals. The Company matches 100% of each participant contribution, up to 4% for all eligible employees. Matching
contributions vest immediately. Participants are entitled to receive distributions of all vested amounts beginning at age 59 1/2.
Matching contributions to all eligible non-executive participants charged to expense were $ 134,766
and $ 72,520 for the years
ending December 31, 2024 and 2023, respectively. The plan is subject to the annual IRS elective deferral limit of $ 23,000
per employee for 2024 and $7,500
catch-up for 50 and over .
NOTE 14 – SEGMENT REPORTING
The Company operates as a single reportable segment, as
the Chief Operating Decision Maker (“CODM”), the Chief Executive Officer (“CEO”), evaluates the business on a consolidated
basis and does not receive discrete financial information for multiple business units.
Measure of Segment Profit or Loss
The CODM assesses the Company's financial performance based
on operating loss, which aligns with the amount reported in the statements of comprehensive loss. The following table presents a
reconciliation of segment operating loss to net loss:
Schedule of reconciliation of segment
operating loss
2024
2023
NET SALES
$ 95,605
$ 40,502
COST OF SALES
7,395
2,513
GROSS PROFIT
88,210
37,989
OPERATING EXPENSES
Research and development
16,806,548
15,903,689
General and administrative
6,370,805
5,359,565
23,177,353
21,263,254
SEGMENT OPERATING LOSS
( 23,089,143 )
( 21,225,265 )
OTHER INCOME (EXPENSE)
Interest income
926,854
657,546
Commitment fee
( 154,210 )
( 673,578 )
(Loss) gain on disposal of property and equipment and intangible assets
( 213,440 )
215,509
Other (expense)
( 5,102 )
( 12,244 )
NET LOSS
$ ( 22,535,041 )
$ ( 21,038,032 )
F- 28
LIGHTWAVE LOGIC, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2024 AND 2023
Significant Segment Expenses
The Company considers the following as significant expenses
in evaluating its segment performance:
• Research and Development: includes costs related to personnel, laboratory and wafer
fabrication materials and supplies, prototype device development and wafer fabrication expenses, and third-party consulting costs aimed
at developing high-performance electro-optic polymer materials.
• General and Administrative: includes personnel costs, professional fees, and other overhead
expenses.
• Cost of Sales: represents labor costs, material costs and manufacturing overhead costs
associated with the production of materials transferred to the customer under the technology license and material supply agreement at
the Company’s facility.
Since the Company has only one reportable segment, no additional
segment disclosures are required beyond entity-wide disclosures presented below.
Entity-Wide Disclosures
• Geographic Revenue Information: For the year ended December 31,
2024, 14 %
of the Company's net sales were generated in the United States and 86 %
internationally. For the year ended December 31, 2023, 100 % of the Company’s
net sales were generated internationally.
• Major Customers: The Company has one customer that accounted for 10 % or more of total
revenue.
Chief Operating Decision Maker (CODM)
The CODM of the Company is the Chief Executive Officer (CEO),
who is responsible for evaluating financial results and making resource allocation decisions.
NOTE
15 – SUBSEQUENT EVENTS
On March 17, 2025, the Company entered into a purchase
agreement with an institutional investor to sell up to $ 30,000,000
of common stock over a 36-month period. Concurrently with entering into the purchase agreement, the Company also entered
into a registration rights agreement which provides the institutional investor with certain registration rights related to the shares
issued under the purchase agreement.
F-29